PKC activity was found to be elevated in the fibroblasts of type 1 diabetic patients, while decreased PKC activity in patients with systemic lupus erythematosus (SLE) was correlated with the state of their condition [122,248,249]. This evidence concerns the gene PRRT2 and systemic lupus erythematosus.